<DOC>
	<DOCNO>NCT00160498</DOCNO>
	<brief_summary>A double blind study examine safety efficacy different dosage lercanidipine normal weight obese patient hypertension</brief_summary>
	<brief_title>Testing Efficacy Different Dosages Lercanidipine Reduce Hypertensive Blood Pressure Normal Weight Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lercanidipine</mesh_term>
	<criteria>Body Mass Index ( BMI ) : 18.0 24.9 30.0 39.9 kg/m2 ( extremes include ) ; Essential hypertension I II WHO : 140 mmHg ≤ BPs ≤ 179 mmHg BPd ≤ 109 mmHg end placebo runin phase ; Secondary hypertension ; Diabetes mellitus type 1 , insulin dependent diabetes mellitus type 2 , fast blood glucose ≥ 160 mg/dl ; Subjects keep hypocaloric diet ( except special diet diabetic ) reduce body weight ; History presence angioneurotic oedema ; Subjects develop hypertensive crisis washout placebo runin period ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Lercanidipine , calcium antagonist , hypertension , obesity</keyword>
</DOC>